scholarly journals HUMAN LEUKEMIC CELLS CYTOCHEMICAL STUDIES ON ACIDIC NUCLEAR PROTEINS

1974 ◽  
Vol 22 (1) ◽  
pp. 40-45 ◽  
Author(s):  
L. S. DESAI ◽  
G. E. FOLEY

Utilizing staining with alkaline fast green (pH 8.1) and toluidine blue O (pH 9.0) stains, the nuclear basic and acidic protein content of individual human lymphocytic cells has been quantitated cytochemically with high resolution, rapid scanning instruments. There were distinct differences in the distribution patterns of the acidic and basic proteins in these human lymphocytic cells. Nucleoli were densely stained by toluidine blue O, confirming the presence of acidic proteins. The acidic nuclear proteins:DNA and basic nuclear proteins:DNA ratios are consistent and quantitatively similar, irrespective of the diagnostic category from which the cells derived and there was a definite correlation between nuclear proteins and DNA content. However, the acidic nuclear proteins represented a larger proportion of the total dry mass of the cell than did the basic nuclear proteins, an observation which may prove to be of interest with respect to control mechanisms.

1972 ◽  
Vol 20 (9) ◽  
pp. 703-709 ◽  
Author(s):  
L. E. DE BAULT

The cytocentrifuge has been used as a tool to obtain preparations from suspension cultures suitable for quantitative cytochemical analysis. Three continuous suspension cultures of human lymphocytic cells (CCRF-CEM, acute lymphoblastic leukemia; CCRF-RKB, infectious mononucleosis; and EB-3, Burkitt's lymphoma) and a suspension of mouse inguinal lymph node lymphocytes were examined for quantitative differential effects on cellular dry mass and Feulgen-deoxyribonucleic acid (DNA) contents caused by cytocentrifugation. When using a cytocentrifuge technique which results in a dry preparation, a quantitative loss was observed for cellular dry mass but not for Feulgen-DNA. However, if a medium which prevented bursting, swelling or loss of cellular constituents during cytocentrifugation was used and if the preparation was maintained in the wet state (no air-drying), acceptable preparations for both dry mass and Feulgen-DNA quantitation can be obtained. These and other observations on centrifugal force, centrifuge time and suspending medium emphasize the importance of specimen preparation when quantitating cell parameters that may themselves be altered by the method of preparation.


Chromosoma ◽  
1972 ◽  
Vol 38 (3) ◽  
pp. 329-340 ◽  
Author(s):  
L. S. Desai ◽  
L. E. De Bault ◽  
G. Morrissey ◽  
G. E. Foley

Blood ◽  
2004 ◽  
Vol 103 (6) ◽  
pp. 2299-2307 ◽  
Author(s):  
Masayuki Okada ◽  
Souichi Adachi ◽  
Tsuyoshi Imai ◽  
Ken-ichiro Watanabe ◽  
Shin-ya Toyokuni ◽  
...  

Abstract Caspase-independent programmed cell death can exhibit either an apoptosis-like or a necrosis-like morphology. The ABL kinase inhibitor, imatinib mesylate, has been reported to induce apoptosis of BCR-ABL–positive cells in a caspase-dependent fashion. We investigated whether caspases alone were the mediators of imatinib mesylate–induced cell death. In contrast to previous reports, we found that a broad caspase inhibitor, zVAD-fmk, failed to prevent the death of imatinib mesylate–treated BCR-ABL–positive human leukemic cells. Moreover, zVAD-fmk–preincubated, imatinib mesylate–treated cells exhibited a necrosis-like morphology characterized by cellular pyknosis, cytoplasmic vacuolization, and the absence of nuclear signs of apoptosis. These cells manifested a loss of the mitochondrial transmembrane potential, indicating the mitochondrial involvement in this caspase-independent necrosis. We excluded the participation of several mitochondrial factors possibly involved in caspase-independent cell death such as apoptosis-inducing factor, endonuclease G, and reactive oxygen species. However, we observed the mitochondrial release of the serine protease Omi/HtrA2 into the cytosol of the cells treated with imatinib mesylate or zVAD-fmk plus imatinib mesylate. Furthermore, serine protease inhibitors prevented the caspase-independent necrosis. Taken together, our results suggest that imatinib mesylate induces a caspase-independent, necrosis-like programmed cell death mediated by the serine protease activity of Omi/HtrA2.


1991 ◽  
Vol 15 (8) ◽  
pp. 766 ◽  
Author(s):  
Ronald D. Barr ◽  
Delsworth Harnish

Biochemistry ◽  
1988 ◽  
Vol 27 (24) ◽  
pp. 8861-8869 ◽  
Author(s):  
Mary K. Danks ◽  
Carla A. Schmidt ◽  
Margaret C. Cirtain ◽  
D. Parker Suttle ◽  
William T. Beck

Author(s):  
M. Seligmann ◽  
L. B. Vogler ◽  
P. Guglielmi ◽  
J. C. Brouet ◽  
J. L. Preud’homme

1991 ◽  
Vol 27 ◽  
pp. S65 ◽  
Author(s):  
G. Barrera ◽  
R. Muraca ◽  
C. Di Mauro ◽  
V.M. Fazio ◽  
M.U. Dianzani

Sign in / Sign up

Export Citation Format

Share Document